Jointly discovered KAT6i molecule originating from Australian research has initiated Phase 3 in HR+ HER2- Breast Cancer with Pfizer Inc
- Written by PR Newswire Asia - Daily Bulletin Au RSS
Australian scientists who discovered how to "turn off" genes that make cancer cells grow are celebrating the next phase of development – with Pfizer's first in class KAT6 inhibitor PF-07248144 now moving to the next stages of clinical investigation.
MELBOURNE, Australia, Sept. 15, 2025 /PRNewswire/ -- Australian biotechnology investment and...